Apr 02, 2019 8:00am EDT Pieris Pharmaceuticals Presents Preclinical Data for GPC3/4-1BB Bispecific PRS-342 at the 2019 American Association for Cancer Research (AACR) Annual Meeting
Mar 12, 2019 7:00am EDT Pieris Pharmaceuticals Reports 2018 Year-End Cash Position and Provides Corporate Update
Mar 06, 2019 8:00am EST Pieris Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference
Mar 05, 2019 8:00am EST Pieris Pharmaceuticals to Host Full-Year 2018 Investor Call and Corporate Update on March 12, 2019
Nov 07, 2018 7:00am EST Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Oct 31, 2018 8:00am EDT Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018
Oct 25, 2018 8:16am EDT Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors
Oct 02, 2018 8:00am EDT Pieris Pharmaceuticals to Present Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/ONC0055 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
